Solutions

Find more information here about EIFO’s solutions and offer to companies, financial institutions, fund investors, business angels, and future partners.

Loan financing for Danish companies Equity investment for Danish companies Financing for foreign customers Insuring international business

Partnership and network For funds For business angels

Ambition

EIFO’s ambition is to grow the Danish economy and green the globe. We take our social responsibility seriously as we adopt a dedicated ESG approach in our transactions.

We grow the Danish economy and green the globe EIFO’s approach to ESG

Knowledge

EIFO has a lot of expert knowledge to share with our surroundings. Get the latest news and find inspiration in our knowledge hub (available in English from May 2023).

News Knowledge hub (in Danish) Countries (ekf.dk)

About EIFO

EIFO provides a single point of access for Danish companies requiring risk-tolerant government financing. Learn more about our legal foundation, management, annual reports, policies etc. here.

Legal basis The Executive Team Board of Directors Policies

Annual report Career and vacancies

Opportunities to join

EIFO'S portfolio companies

114

companies

174

Jobs

Synklino

Locations

Lyngby, Denmark

industry

Biotechnology · DeepTech · Health

Size

11-50 employees

Stage

Series A

founded in

2017

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection. The company's immunotoxin is highly effective, potent and fast-acting that kills lytic and latently infected cells, enabling patients to have long-term health benefits for transplantation.

Something looks off?

Open jobs at Synklino

This company does not have jobs relevant to this job board at this time.

To view all their jobs, visit their website.

Privacy policy Cookie policy